首页 > 最新文献

Bladder (San Francisco, Calif.)最新文献

英文 中文
Comparison of 2D and 3D ultrasound methods to measure serial bladder volumes during filling: Steps toward development of non-invasive ultrasound urodynamics 二维和三维超声方法在膀胱充盈过程中测量膀胱容积的比较:无创超声尿动力学发展的步骤
Pub Date : 2018-01-04 DOI: 10.14440/bladder.2018.565
Anna S Nagle, Rachel J. Bernardo, Jary Varghese, L. Carucci, A. Klausner, J. Speich
OBJECTIVES Non-invasive methods to objectively characterize overactive bladder (OAB) and other forms of voiding dysfunction using real-time ultrasound are currently under development but require accurate and precise serial measurements of bladder volumes during filling. This study’s objective was to determine the most accurate and precise ultrasound-based method of quantifying serial bladder volumes during urodynamics (UD). METHODS Twelve female participants with OAB completed an extended UD procedure with the addition of serial bladder ultrasound images captured once per minute. Bladder volume was measured using three ultrasound methods: (1) Vspheroid: two-dimensional (2D) method calculated assuming spheroid geometry; (2) Vbih: 2D correction method obtained by multiplying Vspheroid by a previously derived correction factor of 1.375; and (3) V3D: three-dimensional (3D) method obtained by manually tracing the bladder outline in six planes automatically reconstructed into a solid rendered volume. These volumes were compared to a control (Vcontrol) obtained by adding UD infused volume and the volume of estimated urine production. RESULTS Based on linear regression analysis, both Vbih and V3D were fairly accurate estimators of Vcontrol, but V3D was more precise. Vspheroid significantly underestimated Vcontrol. CONCLUSIONS Although the Vbih and V3D methods were more accurate than the more-commonly used Vspheroid method for measuring bladder volumes during UD, the V3D method was the most precise and could best account for non-uniform bladder geometries. Therefore, the V3D method may represent the best tool required for the continued development of non-invasive methods to diagnose OAB and other forms of voiding dysfunction.
目的使用实时超声客观表征膀胱过度活动(OAB)和其他形式排尿功能障碍的非侵入性方法目前正在开发中,但需要在充盈过程中准确、精确地连续测量膀胱容积。本研究的目的是确定在尿动力学(UD)过程中量化系列膀胱容积的最准确和精确的基于超声的方法。方法12名OAB女性参与者完成了一项扩展的UD程序,增加了每分钟拍摄一次的连续膀胱超声图像。使用三种超声方法测量膀胱体积:(1)V球体:假设球体几何形状计算的二维(2D)方法;(2) Vbih:通过将Vglobe乘以先前导出的1.375的校正因子而获得的2D校正方法;和(3)V3D:通过在自动重建为实体渲染体积的六个平面中手动跟踪膀胱轮廓而获得的三维(3D)方法。将这些体积与通过添加UD输注的体积和估计的尿液产生的体积而获得的对照(Vcontrol)进行比较。结果基于线性回归分析,Vbih和V3D都是Vcontrol的相当准确的估计量,但V3D更准确。Vglobet显著低估了Vcontrol。结论尽管在UD期间,Vbih和V3D方法比更常用的Vglobe方法更准确地测量膀胱体积,但V3D方法是最准确的,并且可以最好地解释不均匀的膀胱几何形状。因此,V3D方法可能是继续开发诊断OAB和其他形式的排尿功能障碍的非侵入性方法所需的最佳工具。
{"title":"Comparison of 2D and 3D ultrasound methods to measure serial bladder volumes during filling: Steps toward development of non-invasive ultrasound urodynamics","authors":"Anna S Nagle, Rachel J. Bernardo, Jary Varghese, L. Carucci, A. Klausner, J. Speich","doi":"10.14440/bladder.2018.565","DOIUrl":"https://doi.org/10.14440/bladder.2018.565","url":null,"abstract":"OBJECTIVES Non-invasive methods to objectively characterize overactive bladder (OAB) and other forms of voiding dysfunction using real-time ultrasound are currently under development but require accurate and precise serial measurements of bladder volumes during filling. This study’s objective was to determine the most accurate and precise ultrasound-based method of quantifying serial bladder volumes during urodynamics (UD). METHODS Twelve female participants with OAB completed an extended UD procedure with the addition of serial bladder ultrasound images captured once per minute. Bladder volume was measured using three ultrasound methods: (1) Vspheroid: two-dimensional (2D) method calculated assuming spheroid geometry; (2) Vbih: 2D correction method obtained by multiplying Vspheroid by a previously derived correction factor of 1.375; and (3) V3D: three-dimensional (3D) method obtained by manually tracing the bladder outline in six planes automatically reconstructed into a solid rendered volume. These volumes were compared to a control (Vcontrol) obtained by adding UD infused volume and the volume of estimated urine production. RESULTS Based on linear regression analysis, both Vbih and V3D were fairly accurate estimators of Vcontrol, but V3D was more precise. Vspheroid significantly underestimated Vcontrol. CONCLUSIONS Although the Vbih and V3D methods were more accurate than the more-commonly used Vspheroid method for measuring bladder volumes during UD, the V3D method was the most precise and could best account for non-uniform bladder geometries. Therefore, the V3D method may represent the best tool required for the continued development of non-invasive methods to diagnose OAB and other forms of voiding dysfunction.","PeriodicalId":72421,"journal":{"name":"Bladder (San Francisco, Calif.)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44762008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Comparison of 2D and 3D ultrasound methods to measure serial bladder volumes during filling: Steps toward development of non-invasive ultrasound urodynamics. 二维和三维超声方法在膀胱充盈过程中测量膀胱容积的比较:无创超声尿动力学发展的步骤。
Pub Date : 2018-01-01 Epub Date: 2018-01-04
Anna S Nagle, Rachel J Bernardo, Jary Varghese, Laura R Carucci, Adam P Klausner, John E Speich

Objectives: Non-invasive methods to objectively characterize overactive bladder (OAB) and other forms of voiding dysfunction using real-time ultrasound are currently under development but require accurate and precise serial measurements of bladder volumes during filling. This study's objective was to determine the most accurate and precise ultrasound-based method of quantifying serial bladder volumes during urodynamics (UD).

Methods: Twelve female participants with OAB completed an extended UD procedure with the addition of serial bladder ultrasound images captured once per minute. Bladder volume was measured using three ultrasound methods: (1) Vspheroid: two-dimensional (2D) method calculated assuming spheroid geometry; (2) Vbih: 2D correction method obtained by multiplying Vspheroid by a previously derived correction factor of 1.375; and (3) V3D: three-dimensional (3D) method obtained by manually tracing the bladder outline in six planes automatically reconstructed into a solid rendered volume. These volumes were compared to a control (Vcontrol) obtained by adding UD infused volume and the volume of estimated urine production.

Results: Based on linear regression analysis, both Vbih and V3D were fairly accurate estimators of Vcontrol, but V3D was more precise. Vspheroid significantly underestimated Vcontrol.

Conclusions: Although the Vbih and V3D methods were more accurate than the more-commonly used Vspheroid method for measuring bladder volumes during UD, the V3D method was the most precise and could best account for non-uniform bladder geometries. Therefore, the V3D method may represent the best tool required for the continued development of non-invasive methods to diagnose OAB and other forms of voiding dysfunction.

目的:利用实时超声客观表征膀胱过度活动(OAB)和其他形式的排尿功能障碍的非侵入性方法目前正在开发中,但需要在充盈过程中精确和精确地连续测量膀胱体积。本研究的目的是确定最准确和精确的基于超声的方法来量化尿动力学(UD)期间的连续膀胱体积。方法:12名患有OAB的女性参与者完成了一个扩展的UD程序,并增加了每分钟一次的连续膀胱超声图像。膀胱体积测量采用三种超声方法:(1)椭球体:假设椭球体几何计算二维(2D)方法;(2) Vbih:由Vspheroid乘以先前导出的校正因子1.375得到的二维校正方法;(3) V3D:通过手动跟踪膀胱轮廓在六个平面上获得的三维(3D)方法,自动重建为实体渲染体。将这些量与通过添加UD输注量和估计尿量获得的对照(Vcontrol)进行比较。结果:基于线性回归分析,Vbih和V3D都是较为准确的Vcontrol估计量,但V3D更为精确。Vspheroid明显低估了v控制。结论:尽管Vbih和V3D方法在UD期间测量膀胱体积比更常用的Vspheroid方法更准确,但V3D方法最精确,可以最好地解释膀胱几何形状不均匀的情况。因此,V3D方法可能是继续发展无创方法诊断OAB和其他形式排尿功能障碍所需的最佳工具。
{"title":"Comparison of 2D and 3D ultrasound methods to measure serial bladder volumes during filling: Steps toward development of non-invasive ultrasound urodynamics.","authors":"Anna S Nagle,&nbsp;Rachel J Bernardo,&nbsp;Jary Varghese,&nbsp;Laura R Carucci,&nbsp;Adam P Klausner,&nbsp;John E Speich","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>Non-invasive methods to objectively characterize overactive bladder (OAB) and other forms of voiding dysfunction using real-time ultrasound are currently under development but require accurate and precise serial measurements of bladder volumes during filling. This study's objective was to determine the most accurate and precise ultrasound-based method of quantifying serial bladder volumes during urodynamics (UD).</p><p><strong>Methods: </strong>Twelve female participants with OAB completed an extended UD procedure with the addition of serial bladder ultrasound images captured once per minute. Bladder volume was measured using three ultrasound methods: (1) V<sub>spheroid</sub>: two-dimensional (2D) method calculated assuming spheroid geometry; (2) V<sub>bih</sub>: 2D correction method obtained by multiplying V<sub>spheroid</sub> by a previously derived correction factor of 1.375; and (3) V<sub>3D</sub>: three-dimensional (3D) method obtained by manually tracing the bladder outline in six planes automatically reconstructed into a solid rendered volume. These volumes were compared to a control (V<sub>control</sub>) obtained by adding UD infused volume and the volume of estimated urine production.</p><p><strong>Results: </strong>Based on linear regression analysis, both V<sub>bih</sub> and V<sub>3D</sub> were fairly accurate estimators of V<sub>control</sub>, but V<sub>3D</sub> was more precise. V<sub>spheroid</sub> significantly underestimated V<sub>control</sub>.</p><p><strong>Conclusions: </strong>Although the V<sub>bih</sub> and V<sub>3D</sub> methods were more accurate than the more-commonly used V<sub>spheroid</sub> method for measuring bladder volumes during UD, the V<sub>3D</sub> method was the most precise and could best account for non-uniform bladder geometries. Therefore, the V<sub>3D</sub> method may represent the best tool required for the continued development of non-invasive methods to diagnose OAB and other forms of voiding dysfunction.</p>","PeriodicalId":72421,"journal":{"name":"Bladder (San Francisco, Calif.)","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/63/10/bladder-5-1-e32.PMC5771657.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35754471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emetine reduces the effective dose of cisplatin or carboplatin required to inhibit bladder cancer cell proliferation 埃美汀降低抑制膀胱癌症细胞增殖所需的顺铂或卡铂的有效剂量
Pub Date : 2017-12-26 DOI: 10.14440/BLADDER.2017.570
V. Davidson, D. Patel, R. Flanigan, G. Gupta, K. Foreman
OBJECTIVE: We analyzed a novel therapeutic combination of emetine dihydrochloride added to standard of care chemotherapeutic agents (cisplatin, carboplatin, gemcitabine) in human muscle-invasive bladder cancer cell lines to determine if emetine enhanced their anti-tumor activity.METHODS: Cells were treated with emetine, cisplatin (or carboplatin), and gemcitabine for 24–96 h in vitro. Cell proliferation, apoptosis, autophagy, cell cycle distribution and colony formation were analyzed. RESULTS: Addition of low dose emetine enhanced the anti-proliferative activity of cisplatin-gemcitabine and carboplatin-gemcitabine against muscle-invasive bladder cancer, but not normal urothelial cells. Importantly, lower doses of cisplatin and carboplatin were required to achieve significant growth inhibition when emetine was included in the therapy. Treatment resulted in a combination of growth arrest, apoptosis and autophagy.CONCLUSIONS: The inclusion of low dose emetine as part of multi-modal therapy for muscle-invasive bladder cancer could benefit patients by enhancing the anti-tumor activity of standard of care chemotherapy. It allowed for dose reduction of cisplatin and increased the efficacy of carboplatin. This may allow more patients currently unfit for cisplatin-based therapy to benefit from treatment.
目的:我们分析了在标准护理化学治疗剂(顺铂、卡铂、吉西他滨)中加入盐酸依梅汀的新型治疗组合,以确定依梅汀是否增强了其抗肿瘤活性。方法:在体外用催吐剂、顺铂(或卡铂)和吉西他滨处理细胞24-96小时。分析细胞增殖、凋亡、自噬、细胞周期分布和集落形成。结果:低剂量依替丁的加入增强了顺铂-麦西他滨和卡铂-麦西他滨对肌肉浸润性膀胱癌症的抗增殖活性,但不增强正常尿路上皮细胞的抗增殖作用。重要的是,当催吐剂被纳入治疗时,需要较低剂量的顺铂和卡铂来实现显著的生长抑制。治疗导致生长停滞、细胞凋亡和自噬。结论:将低剂量依吐丁作为多模式治疗肌肉浸润性膀胱癌症的一部分,可以提高标准护理化疗的抗肿瘤活性,从而使患者受益。它可以减少顺铂的剂量,并提高卡铂的疗效。这可能会让更多目前不适合顺铂治疗的患者从治疗中受益。
{"title":"Emetine reduces the effective dose of cisplatin or carboplatin required to inhibit bladder cancer cell proliferation","authors":"V. Davidson, D. Patel, R. Flanigan, G. Gupta, K. Foreman","doi":"10.14440/BLADDER.2017.570","DOIUrl":"https://doi.org/10.14440/BLADDER.2017.570","url":null,"abstract":"OBJECTIVE: We analyzed a novel therapeutic combination of emetine dihydrochloride added to standard of care chemotherapeutic agents (cisplatin, carboplatin, gemcitabine) in human muscle-invasive bladder cancer cell lines to determine if emetine enhanced their anti-tumor activity.METHODS: Cells were treated with emetine, cisplatin (or carboplatin), and gemcitabine for 24–96 h in vitro. Cell proliferation, apoptosis, autophagy, cell cycle distribution and colony formation were analyzed. RESULTS: Addition of low dose emetine enhanced the anti-proliferative activity of cisplatin-gemcitabine and carboplatin-gemcitabine against muscle-invasive bladder cancer, but not normal urothelial cells. Importantly, lower doses of cisplatin and carboplatin were required to achieve significant growth inhibition when emetine was included in the therapy. Treatment resulted in a combination of growth arrest, apoptosis and autophagy.CONCLUSIONS: The inclusion of low dose emetine as part of multi-modal therapy for muscle-invasive bladder cancer could benefit patients by enhancing the anti-tumor activity of standard of care chemotherapy. It allowed for dose reduction of cisplatin and increased the efficacy of carboplatin. This may allow more patients currently unfit for cisplatin-based therapy to benefit from treatment.","PeriodicalId":72421,"journal":{"name":"Bladder (San Francisco, Calif.)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49604920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Staphylococcus aureus urinary tract bacteriuria: single-institutional antibiotic susceptibility trends over a decade 金黄色葡萄球菌尿路细菌尿:十年来单一机构抗生素敏感性趋势
Pub Date : 2017-09-28 DOI: 10.14440/BLADDER.2017.478
L. Toner, N. Papa, M. Perera, S. Aliyu, Harveer Dev, N. Lawrentschuk, S. Al-hayek
Objectives: Methicillin resistant Staphylococcus aureus (MRSA) is a troublesome pathogen which is difficult for clinicians to treat. The purpose of this surveillance program is to assess the prevalence of MRSA urinary tract infections and determine risk factors for methicillin resistance in adults amongst urinary isolates of SA and to describe the antibiotic susceptibilities to guide empirical therapy.Methods: From 2005 through to 2014, we retrospectively reviewed urine cultures recorded in a laboratory database at a university hospital in Cambridge, UK. Susceptibility testing was performed by BSAC (British Society of Antimicrobial Chemotherapy) disc diffusion testing and reported for fluoroquinolones, gentamicin, nitrofurantoin, linezolid, trimethoprim and vancomycin. Samples were denoted “MRSA” if they were resistant to oxacillin or cefoxitin.Results: In total, 690 cultures were positive for SA, of which 293 (42.5%) were methicillin resistant. The number of SA bacteriuria decreased from around 100 per year to 40 per year. The proportion demonstrating methicillin resistance decreased from around 60% to around 20%. Both methicillin-sensitive Staphylococcus aureus (MSSA) and MRSA isolates were susceptible to vancomycin and nitrofurantoin. MRSA isolates demonstrated some increased resistance to trimethoprim and gentamicin and greatly increased resistance to fluoroquinolones. Urinary catheterization and increasing age were risk factors for methicillin resistance.Conclusion: The incidence of SA and MRSA bacteriuria decreased during the study period. A high degree of resistance to fluoroquinolones was observed in MRSA compared to MSSA. Analysis of antibiotic susceptibility profiles suggests nitrofurantoin and trimethoprim may be useful in treating uncomplicated MSSA and MRSA urinary tract infections without concurrent bacteremia.
目的:耐甲氧西林金黄色葡萄球菌(MRSA)是临床治疗的难点病原体。本监测项目的目的是评估MRSA尿路感染的患病率,确定尿路分离的SA成人中甲氧西林耐药性的危险因素,并描述抗生素敏感性以指导经验性治疗。方法:从2005年到2014年,我们回顾性地回顾了英国剑桥大学医院实验室数据库中记录的尿液培养。采用BSAC (British Society of Antimicrobial Chemotherapy)圆盘扩散试验对氟喹诺酮类药物、庆大霉素、呋喃妥英、利奈唑胺、甲氧苄啶和万古霉素进行药敏试验。如果样品对奥西林或头孢西丁耐药,则标记为“MRSA”。结果:SA阳性培养690例,耐甲氧西林293例(42.5%)。SA细菌的数量从每年100个左右减少到每年40个。显示甲氧西林耐药的比例从60%左右下降到20%左右。甲氧西林敏感金黄色葡萄球菌(MSSA)和MRSA分离株均对万古霉素和呋喃妥因敏感。MRSA分离株对甲氧苄啶和庆大霉素的耐药性有所增加,对氟喹诺酮类药物的耐药性大大增加。导尿和年龄增长是甲氧西林耐药的危险因素。结论:在研究期间,SA和MRSA细菌的发病率下降。与MSSA相比,MRSA对氟喹诺酮类药物具有高度耐药性。抗生素敏感性分析表明,呋喃妥因和甲氧苄啶可用于治疗无并发菌血症的单纯MSSA和MRSA尿路感染。
{"title":"Staphylococcus aureus urinary tract bacteriuria: single-institutional antibiotic susceptibility trends over a decade","authors":"L. Toner, N. Papa, M. Perera, S. Aliyu, Harveer Dev, N. Lawrentschuk, S. Al-hayek","doi":"10.14440/BLADDER.2017.478","DOIUrl":"https://doi.org/10.14440/BLADDER.2017.478","url":null,"abstract":"Objectives: Methicillin resistant Staphylococcus aureus (MRSA) is a troublesome pathogen which is difficult for clinicians to treat. The purpose of this surveillance program is to assess the prevalence of MRSA urinary tract infections and determine risk factors for methicillin resistance in adults amongst urinary isolates of SA and to describe the antibiotic susceptibilities to guide empirical therapy.Methods: From 2005 through to 2014, we retrospectively reviewed urine cultures recorded in a laboratory database at a university hospital in Cambridge, UK. Susceptibility testing was performed by BSAC (British Society of Antimicrobial Chemotherapy) disc diffusion testing and reported for fluoroquinolones, gentamicin, nitrofurantoin, linezolid, trimethoprim and vancomycin. Samples were denoted “MRSA” if they were resistant to oxacillin or cefoxitin.Results: In total, 690 cultures were positive for SA, of which 293 (42.5%) were methicillin resistant. The number of SA bacteriuria decreased from around 100 per year to 40 per year. The proportion demonstrating methicillin resistance decreased from around 60% to around 20%. Both methicillin-sensitive Staphylococcus aureus (MSSA) and MRSA isolates were susceptible to vancomycin and nitrofurantoin. MRSA isolates demonstrated some increased resistance to trimethoprim and gentamicin and greatly increased resistance to fluoroquinolones. Urinary catheterization and increasing age were risk factors for methicillin resistance.Conclusion: The incidence of SA and MRSA bacteriuria decreased during the study period. A high degree of resistance to fluoroquinolones was observed in MRSA compared to MSSA. Analysis of antibiotic susceptibility profiles suggests nitrofurantoin and trimethoprim may be useful in treating uncomplicated MSSA and MRSA urinary tract infections without concurrent bacteremia.","PeriodicalId":72421,"journal":{"name":"Bladder (San Francisco, Calif.)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46304386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Cystectomy survival outcomes: A single centre experience in Australia 膀胱切除术存活结果:澳大利亚单中心经验
Pub Date : 2017-08-22 DOI: 10.14440/BLADDER.2017.552
Richard Hoffmann, C. Logan, M. O’Callaghan, D. Foreman
Objective: Survival following cystectomy is influenced by gender, age and initial pathology. We report on variation in biopsy versus final surgical pathology and its impact on survival, five year survival of those undergoing cystectomy for bladder urothelial carcinoma, and evaluate any difference between gender and age.Methods: Patients were selected from our hospital cancer database who underwent a cystectomy for bladder urothelial carcinoma between 1987 and 2015. Patients were considered as having bladder cancer if they had muscle invasive cancer, non-muscle invasive cancer or carcinoma in situ on their final biopsy pathology. Pathology was recorded at last cystoscopy before surgery and based on surgical specimen.Results: One hundred and twenty-five patients were included, 71% male, and 29% female, with a median age at cystectomy of 67.1 years. Fifty-seven point nine percent of patients had no change between their biopsy and cystectomy histopathology and 18.3% of patients were downgraded, 16.6% of patients were upgraded, and 7.1% had incomplete pathology data. Median survival was 4.6 years and overall five year survival 58.2%. There was no significant difference in survival between genders and no difference when comparing between gender and age > 70 and < 70 years. There was no statistical difference in survival between patients who had their final pathology upgraded, downgraded, or confirmed.Conclusions: We found lower rates of variation in biopsy versus surgical pathology than reported elsewhere and did not observe a significant association with survival. Our survival outcomes are similar to those within the literature. Gender did not impact on survival, even when comparing between age > 70 and < 70 years.
目的:膀胱切除术后的生存受性别、年龄和初始病理的影响。我们报告了活检与最终手术病理的差异及其对生存率的影响,膀胱尿路上皮癌膀胱切除术患者的5年生存率,并评估了性别和年龄之间的差异。方法:从我院肿瘤数据库中选取1987年至2015年间因膀胱尿路上皮癌行膀胱切除术的患者。如果患者在最后的活检病理中患有肌肉浸润性癌、非肌肉浸润性癌或原位癌,则认为患者患有膀胱癌。术前最后一次膀胱镜检查并以手术标本为基础记录病理。结果:纳入125例患者,男性71%,女性29%,膀胱切除术时的中位年龄为67.1岁。57.9%的患者活检和膀胱切除术的组织病理学没有变化,18.3%的患者降级,16.6%的患者升级,7.1%的患者病理数据不完整。中位生存期为4.6年,总5年生存率为58.2%。性别间生存率无显著差异,70岁以下与70岁以下性别与年龄间生存率无显著差异。最终病理升级、降级或确诊的患者生存率无统计学差异。结论:我们发现活检与手术病理的变异性比其他地方报道的要低,并且没有观察到与生存的显著关联。我们的生存结果与文献中的相似。性别对生存率没有影响,即使在比较70岁和70岁以下的年龄时也是如此。
{"title":"Cystectomy survival outcomes: A single centre experience in Australia","authors":"Richard Hoffmann, C. Logan, M. O’Callaghan, D. Foreman","doi":"10.14440/BLADDER.2017.552","DOIUrl":"https://doi.org/10.14440/BLADDER.2017.552","url":null,"abstract":"Objective: Survival following cystectomy is influenced by gender, age and initial pathology. We report on variation in biopsy versus final surgical pathology and its impact on survival, five year survival of those undergoing cystectomy for bladder urothelial carcinoma, and evaluate any difference between gender and age.Methods: Patients were selected from our hospital cancer database who underwent a cystectomy for bladder urothelial carcinoma between 1987 and 2015. Patients were considered as having bladder cancer if they had muscle invasive cancer, non-muscle invasive cancer or carcinoma in situ on their final biopsy pathology. Pathology was recorded at last cystoscopy before surgery and based on surgical specimen.Results: One hundred and twenty-five patients were included, 71% male, and 29% female, with a median age at cystectomy of 67.1 years. Fifty-seven point nine percent of patients had no change between their biopsy and cystectomy histopathology and 18.3% of patients were downgraded, 16.6% of patients were upgraded, and 7.1% had incomplete pathology data. Median survival was 4.6 years and overall five year survival 58.2%. There was no significant difference in survival between genders and no difference when comparing between gender and age > 70 and < 70 years. There was no statistical difference in survival between patients who had their final pathology upgraded, downgraded, or confirmed.Conclusions: We found lower rates of variation in biopsy versus surgical pathology than reported elsewhere and did not observe a significant association with survival. Our survival outcomes are similar to those within the literature. Gender did not impact on survival, even when comparing between age > 70 and < 70 years.","PeriodicalId":72421,"journal":{"name":"Bladder (San Francisco, Calif.)","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42134585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effect of filling rate on cystometric parameters in young and middle aged mice. 灌胃率对中青年小鼠膀胱参数的影响。
Pub Date : 2017-01-01 Epub Date: 2017-02-27 DOI: 10.14440/bladder.2017.88
Alexandra K Kim, Warren G Hill

Objectives: To investigate the effect of changing the bladder filling rate during cystometry in younger (2-3 months) and older (13-14 months) C57BL/6J male mice.

Methods: Cystometry was performed on mice under anesthesia. Voiding cycles were established in each mouse at a pump delivery rate of 17 μl/min. After 30 min, the rate was increased sequentially to 25, 33, 41 and 49 μl/min. Each rate was maintained for 30 min. The following cystometric parameters were quantified: peak pressure amplitude, intercontractile interval (ICI), compliance, micturition pressure threshold and voiding efficiency.

Results: Bladder weights were significantly greater in older mice (42 mg vs. 27 mg, P < 0.01), but functional capacities were not different. The pressure amplitudes did not change as filling rate increased, nor did they differ between the 4-month and 13-month-old males. ICIs were not significantly different between young and mature mice. However, both groups exhibited a non-linear reduction in ICI with increasing filling rate, best described by a power curve (R2 > 0.93). Compliance was higher in the older mice at low filling rates (17 and 25 μl/min) but this difference diminished at higher rates. Compliance decreased with increasing flow rate in a non-linear manner, again with greater effects at low filling rates. Micturition pressure thresholds increased with increasing flow rate in a linear manner and older mice began voiding at higher pressures than younger. Both young and old mice exhibited voiding efficiencies of ~70%.

Conclusions: The rate of volume delivery has complex effects on the timing of voiding and compliance. These findings argue for greater standardization of cystometry protocols and further investigation into afferent signaling to higher centers at different filling rates.

目的:观察小(2 ~ 3月龄)和大(13 ~ 14月龄)C57BL/6J雄性小鼠膀胱造膀胱术中膀胱填充率的变化。方法:在麻醉状态下对小鼠进行膀胱测量。每只小鼠以17 μl/min的泵给药率建立排尿周期。30 min后,速率依次增加至25、33、41、49 μl/min。每个速率维持30分钟。量化以下膀胱测量参数:峰值压力幅值、收缩间期(ICI)、顺应性、排尿压力阈值和排尿效率。结果:老年小鼠膀胱重量明显大于老年小鼠(42 mg vs. 27 mg, P < 0.01),但膀胱功能容量无显著差异。压力振幅没有随着充盈率的增加而改变,也没有在4个月和13个月大的雄性之间存在差异。年轻和成熟小鼠的ICIs无显著差异。然而,两组的ICI随填充率的增加呈非线性下降,最佳描述为功率曲线(R2 > 0.93)。老年小鼠在低填充率(17 μl/min和25 μl/min)时依从性较高,但在高填充率时这种差异减小。顺应性随流量的增加呈非线性下降,在低填充率下影响更大。排尿压力阈值随流量的增加呈线性增加,老年小鼠排尿压力高于年轻小鼠。年轻和年老小鼠的排尿效率均为70%。结论:产出率对排尿时间和依从性有复杂的影响。这些发现支持更大标准化的膀胱测量方案,并进一步研究以不同充盈率向更高中心的传入信号。
{"title":"Effect of filling rate on cystometric parameters in young and middle aged mice.","authors":"Alexandra K Kim,&nbsp;Warren G Hill","doi":"10.14440/bladder.2017.88","DOIUrl":"https://doi.org/10.14440/bladder.2017.88","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the effect of changing the bladder filling rate during cystometry in younger (2-3 months) and older (13-14 months) C57BL/6J male mice.</p><p><strong>Methods: </strong>Cystometry was performed on mice under anesthesia. Voiding cycles were established in each mouse at a pump delivery rate of 17 μl/min. After 30 min, the rate was increased sequentially to 25, 33, 41 and 49 μl/min. Each rate was maintained for 30 min. The following cystometric parameters were quantified: peak pressure amplitude, intercontractile interval (ICI), compliance, micturition pressure threshold and voiding efficiency.</p><p><strong>Results: </strong>Bladder weights were significantly greater in older mice (42 mg <i>vs.</i> 27 mg, <i>P</i> < 0.01), but functional capacities were not different. The pressure amplitudes did not change as filling rate increased, nor did they differ between the 4-month and 13-month-old males. ICIs were not significantly different between young and mature mice. However, both groups exhibited a non-linear reduction in ICI with increasing filling rate, best described by a power curve (<i>R</i><sup>2</sup> > 0.93). Compliance was higher in the older mice at low filling rates (17 and 25 μl/min) but this difference diminished at higher rates. Compliance decreased with increasing flow rate in a non-linear manner, again with greater effects at low filling rates. Micturition pressure thresholds increased with increasing flow rate in a linear manner and older mice began voiding at higher pressures than younger. Both young and old mice exhibited voiding efficiencies of ~70%.</p><p><strong>Conclusions: </strong>The rate of volume delivery has complex effects on the timing of voiding and compliance. These findings argue for greater standardization of cystometry protocols and further investigation into afferent signaling to higher centers at different filling rates.</p>","PeriodicalId":72421,"journal":{"name":"Bladder (San Francisco, Calif.)","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/24/64/nihms855756.PMC5443651.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35035901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Sex differences in the MB49 syngeneic, murine model of bladder cancer MB49同基因膀胱癌小鼠模型的性别差异
Pub Date : 2016-02-26 DOI: 10.14440/bladder.2016.73
S. White-Gilbertson, M. Davis, C. Voelkel-Johnson, L. Kasman
OBJECTIVE The MB49 syngeneic, murine model of bladder cancer has been widely used for more than 35 years. In humans, bladder cancer is one third as prevalent in women as in men, with a trend toward lower prevalence in parous compared to nulliparous women. Our objective was to determine if the MB49 bladder cancer model reproduces the sex differences observed in humans, and to determine its sensitivity to testosterone and the pregnancy hormone, human chorionic gonadotropin (hCG). METHODS Male and female C57BL/6 mice were implanted with MB49 murine bladder cancer cells, and observed for tumor growth. MB49 dose responses to hCG and dihydrotestosterone were determined in vitro. RESULTS MB49 tumor growth was significantly greater in male mice than female mice. Pregnancy did not affect MB49 tumor growth in female mice. MB49 cells did not proliferate in response to hCG in vitro and the functional receptor for gonadotropins was absent. Dihydrotestosterone strongly stimulated growth of MB49 cells in vitro. CONCLUSIONS The MB49 murine model of bladder cancer reproduced some aspects of the sex differences observed in humans. Our results suggest that testosterone may stimulate MB49 cell proliferation, which may explain the more rapid MB49 tumor growth observed in male mice.
目的MB49同基因膀胱癌小鼠模型已被广泛应用超过35年。在人类中,膀胱癌在女性中的发病率是男性的三分之一,与未生育女性相比,生育女性的发病率有降低的趋势。我们的目的是确定MB49膀胱癌模型是否再现了在人类中观察到的性别差异,并确定其对睾酮和妊娠激素人绒毛膜促性腺激素(hCG)的敏感性。方法将MB49小鼠膀胱癌细胞植入雄性和雌性C57BL/6小鼠,观察其肿瘤生长情况。体外观察MB49对hCG和双氢睾酮的剂量反应。结果MB49肿瘤在雄性小鼠中的生长明显大于雌性小鼠。妊娠不影响雌性小鼠MB49肿瘤的生长。体外实验中,MB49细胞对hCG没有增殖反应,促性腺激素功能受体缺失。双氢睾酮对MB49细胞的体外生长有强烈的刺激作用。结论MB49小鼠膀胱癌模型再现了在人类中观察到的一些性别差异。我们的研究结果表明,睾酮可能刺激MB49细胞增殖,这可能解释了在雄性小鼠中观察到的MB49肿瘤生长更快。
{"title":"Sex differences in the MB49 syngeneic, murine model of bladder cancer","authors":"S. White-Gilbertson, M. Davis, C. Voelkel-Johnson, L. Kasman","doi":"10.14440/bladder.2016.73","DOIUrl":"https://doi.org/10.14440/bladder.2016.73","url":null,"abstract":"OBJECTIVE The MB49 syngeneic, murine model of bladder cancer has been widely used for more than 35 years. In humans, bladder cancer is one third as prevalent in women as in men, with a trend toward lower prevalence in parous compared to nulliparous women. Our objective was to determine if the MB49 bladder cancer model reproduces the sex differences observed in humans, and to determine its sensitivity to testosterone and the pregnancy hormone, human chorionic gonadotropin (hCG). METHODS Male and female C57BL/6 mice were implanted with MB49 murine bladder cancer cells, and observed for tumor growth. MB49 dose responses to hCG and dihydrotestosterone were determined in vitro. RESULTS MB49 tumor growth was significantly greater in male mice than female mice. Pregnancy did not affect MB49 tumor growth in female mice. MB49 cells did not proliferate in response to hCG in vitro and the functional receptor for gonadotropins was absent. Dihydrotestosterone strongly stimulated growth of MB49 cells in vitro. CONCLUSIONS The MB49 murine model of bladder cancer reproduced some aspects of the sex differences observed in humans. Our results suggest that testosterone may stimulate MB49 cell proliferation, which may explain the more rapid MB49 tumor growth observed in male mice.","PeriodicalId":72421,"journal":{"name":"Bladder (San Francisco, Calif.)","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66606301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Role of consolidative surgical therapy in patients with locally advanced or regionally metastatic bladder cancer. 联合手术治疗在局部晚期或局部转移性膀胱癌患者中的作用。
Pub Date : 2016-01-01 DOI: 10.14440/bladder.2016.89
Mark D Tyson, Sam S Chang, Kirk A Keegan

The effect of radical cystectomy and extended pelvic lymph node dissection (RC/PLND) on the survival of patients with locally advanced and/or regionally metastatic bladder cancer is unknown. However, emerging evidence suggests that there may be survival benefit to a subset of select patients with this disease who demonstrate a response to chemotherapy. This article will review the current literature on the role of RC/PLND in the consolidative treatment of locally advanced and regionally metastatic bladder cancer.

根治性膀胱切除术和扩大盆腔淋巴结清扫术(RC/PLND)对局部晚期和/或局部转移性膀胱癌患者生存的影响尚不清楚。然而,新出现的证据表明,对化疗有反应的部分患者可能有生存益处。本文将回顾目前关于RC/PLND在局部晚期和局部转移性膀胱癌联合治疗中的作用的文献。
{"title":"Role of consolidative surgical therapy in patients with locally advanced or regionally metastatic bladder cancer.","authors":"Mark D Tyson,&nbsp;Sam S Chang,&nbsp;Kirk A Keegan","doi":"10.14440/bladder.2016.89","DOIUrl":"https://doi.org/10.14440/bladder.2016.89","url":null,"abstract":"<p><p>The effect of radical cystectomy and extended pelvic lymph node dissection (RC/PLND) on the survival of patients with locally advanced and/or regionally metastatic bladder cancer is unknown. However, emerging evidence suggests that there may be survival benefit to a subset of select patients with this disease who demonstrate a response to chemotherapy. This article will review the current literature on the role of RC/PLND in the consolidative treatment of locally advanced and regionally metastatic bladder cancer.</p>","PeriodicalId":72421,"journal":{"name":"Bladder (San Francisco, Calif.)","volume":"3 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/46/14/nihms814309.PMC5336315.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10752246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Characterization of the role of HCN channels in β3-adrenoceptor mediated rat bladder relaxation HCN通道在β3-肾上腺素能受体介导的大鼠膀胱舒张中的作用
Pub Date : 2015-07-17 DOI: 10.14440/bladder.2015.44
M. Kashyap, N. Yoshimura, Phillip P Smith, M. Chancellor, P. Tyagi
Objective The second messenger cAMP is involved in both β3 adrenoceptor (β3-AR) mediated detrusor relaxation and the kinetics of Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. Here we characterized the effect HCN channel activation and possible interaction with β3-AR in bladder. Materials and Methods Bladder tissues from Sprague-Dawley rats and Human organ donors were obtained for studying species-specific expression of HCN channels by real-time qPCR and Western Blot. Effect of β3-agonist on rat bladder strips (0.5 × 0.5 × 7 mm in size) was studied during activation and blockade of HCN channels by Lamotrigine and ZD7288, respectively. Results Expression of all four genes encoding for HCN channels (HCN1-4) was detected separately in bladder mucosa and detrusor from human and rat bladders. Species based differences were evident from relatively higher expression of HCN4 isoform in human bladder and that of HCN1 in rat bladder. Western blot confirmed the findings at mRNA level. Cumulative application β3-AR agonist CL316,243 produced a concentration dependent decrease in resting tension of rat bladder strips expressed as integral of mechanical activity. Pre-incubation of HCN channel blocker ZD 7288 opposed the relaxant effect of CL316,243, whereas co-administration of lamotrigine with CL316,243 at equal molar concentrations caused an additive decrease in resting tension. Cumulative addition of ZD7288 and lamotrigine in absence of CL316,243 showed opposing effects on detrusor contractility. Conclusions Species-specific differences were noted in expression of HCN channels in bladder. Opposing effects ZD7288 and Lamotrigine in the action of β3-AR agonist demonstrate possible functional interaction of HCN channels and β3-AR in detrusor contractility.
目的第二信使cAMP参与β3肾上腺素能受体(β3- ar)介导的逼尿肌舒张和超极化激活环核苷酸门控(HCN)通道动力学。本文研究了HCN通道的激活作用及其与膀胱β3-AR的可能相互作用。材料与方法取Sprague-Dawley大鼠和人器官供体膀胱组织,采用实时荧光定量pcr和Western Blot技术研究HCN通道的种特异性表达。在拉莫三嗪和ZD7288分别激活和阻断HCN通道时,研究β3激动剂对大鼠膀胱条(0.5 × 0.5 × 7 mm)的影响。结果编码HCN通道的4个基因(HCN1-4)分别在人和大鼠膀胱粘膜和逼尿肌中表达。人类膀胱中HCN4亚型和大鼠膀胱中HCN1亚型的表达相对较高,可见物种差异。Western blot在mRNA水平上证实了上述结果。累积应用β3-AR激动剂CL316,243使大鼠膀胱条静息张力以机械活动积分表示,产生浓度依赖性降低。HCN通道阻滞剂zd7288与cl316243的松弛作用相反,而拉莫三嗪与cl316243以等摩尔浓度共给药可引起静息张力的加性降低。累积加入ZD7288和拉莫三嗪对逼尿肌收缩力的影响与不加入cl316243相反。结论膀胱HCN通道的表达存在物种特异性差异。ZD7288和拉莫三嗪在β3-AR激动剂作用中的相反作用表明HCN通道和β3-AR在逼尿肌收缩中可能存在功能相互作用。
{"title":"Characterization of the role of HCN channels in β3-adrenoceptor mediated rat bladder relaxation","authors":"M. Kashyap, N. Yoshimura, Phillip P Smith, M. Chancellor, P. Tyagi","doi":"10.14440/bladder.2015.44","DOIUrl":"https://doi.org/10.14440/bladder.2015.44","url":null,"abstract":"Objective The second messenger cAMP is involved in both β3 adrenoceptor (β3-AR) mediated detrusor relaxation and the kinetics of Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. Here we characterized the effect HCN channel activation and possible interaction with β3-AR in bladder. Materials and Methods Bladder tissues from Sprague-Dawley rats and Human organ donors were obtained for studying species-specific expression of HCN channels by real-time qPCR and Western Blot. Effect of β3-agonist on rat bladder strips (0.5 × 0.5 × 7 mm in size) was studied during activation and blockade of HCN channels by Lamotrigine and ZD7288, respectively. Results Expression of all four genes encoding for HCN channels (HCN1-4) was detected separately in bladder mucosa and detrusor from human and rat bladders. Species based differences were evident from relatively higher expression of HCN4 isoform in human bladder and that of HCN1 in rat bladder. Western blot confirmed the findings at mRNA level. Cumulative application β3-AR agonist CL316,243 produced a concentration dependent decrease in resting tension of rat bladder strips expressed as integral of mechanical activity. Pre-incubation of HCN channel blocker ZD 7288 opposed the relaxant effect of CL316,243, whereas co-administration of lamotrigine with CL316,243 at equal molar concentrations caused an additive decrease in resting tension. Cumulative addition of ZD7288 and lamotrigine in absence of CL316,243 showed opposing effects on detrusor contractility. Conclusions Species-specific differences were noted in expression of HCN channels in bladder. Opposing effects ZD7288 and Lamotrigine in the action of β3-AR agonist demonstrate possible functional interaction of HCN channels and β3-AR in detrusor contractility.","PeriodicalId":72421,"journal":{"name":"Bladder (San Francisco, Calif.)","volume":"69 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2015-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66606292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
The human urothelial tight junction: claudin 3 and the ZO-1α+ switch. 人尿路上皮紧密连接:claudin 3和ZO-1α+开关。
Pub Date : 2015-01-01 DOI: 10.14440/bladder.2015.33
Nicholas J Smith, Jennifer Hinley, Claire L Varley, Ian Eardley, Ludwik K Trejdosiewicz, Jennifer Southgate

Objective: Tight junctions are multicomponent structures, with claudin proteins defining paracellular permeability. Claudin 3 is a candidate for the exceptional "tightness" of human urothelium, being localised to the terminal tight junction (TJ) of superficial cells. Our aim was to determine whether claudin 3 plays an instigating and/or a functional role in the urothelial TJ.

Materials and methods: Normal human urothelial (NHU) cells maintained as non-immortalised cell lines were retrovirally-transduced to over-express or silence claudin 3 expression. Stable sublines induced to stratify or differentiate were assessed for TJ formation by immunocytochemistry and transepithelial electrical resistance (TER). Expression of claudin 3, ZO-1 and ZO-1α+ was examined in native urothelium by immunohistochemistry.

Results: Claudin 3 expression was associated with differentiation and development of a tight barrier and along with ZO-1 and ZO-1α+ was localised to the apical tight junction in native urothelium. Knockdown of claudin 3 inhibited formation of a tight barrier in three independent cell lines, however, overexpression of claudin 3 was not sufficient to induce tight barrier development in the absence of differentiation. A differentiation-dependent induction of the ZO-1α+ isoform was found to coincide with barrier formation. Whereas claudin 3 overexpression did not induce the switch to co-expression of ZO-1α-/ZO-1α+, claudin 3 knockdown decreased localisation of ZO-1 to the TJ and resulted in compromised barrier function.

Conclusions: Urothelial cytodifferentiation is accompanied by induction of claudin 3 which is essential for the development of a terminal TJ. A coordinated switch to the ZO-1α+ isotype was also observed and for the first time may indicate that ZO-1α+ is involved in the structural assembly and function of the urothelial terminal TJ.

目的:紧密连接是一种多组分结构,由胞外蛋白决定细胞旁通透性。Claudin 3是人类尿路上皮异常“紧密”的候选者,定位于表层细胞的末端紧密连接(TJ)。我们的目的是确定claudin 3是否在尿路上皮TJ中起诱导和/或功能作用。材料和方法:将正常人类尿路上皮细胞(NHU)维持为非永生化细胞系,通过逆转录病毒转导使其过表达或沉默claudin 3的表达。通过免疫细胞化学和经上皮电阻(TER)评估诱导成层或分化的稳定亚群的TJ形成情况。免疫组化法检测天然尿路上皮中claudin 3、ZO-1和ZO-1α+的表达。结果:Claudin 3的表达与紧密屏障的分化和发育有关,并与ZO-1和ZO-1α+一起定位于天然尿路上皮的顶端紧密连接。在三个独立的细胞系中,敲低claudin 3抑制了紧密屏障的形成,然而,在没有分化的情况下,过表达claudin 3不足以诱导紧密屏障的形成。发现分化依赖性诱导ZO-1α+异构体与屏障形成一致。虽然claudin 3过表达不会诱导ZO-1α-/ZO-1α+的共表达,但claudin 3敲低会降低ZO-1在TJ的定位,导致屏障功能受损。结论:尿路上皮细胞分化伴随着claudin 3的诱导,claudin 3对终末TJ的形成至关重要。我们还观察到ZO-1α+的协同转换,这可能首次表明ZO-1α+参与了尿路上皮末端TJ的结构组装和功能。
{"title":"The human urothelial tight junction: claudin 3 and the ZO-1α<sup>+</sup> switch.","authors":"Nicholas J Smith,&nbsp;Jennifer Hinley,&nbsp;Claire L Varley,&nbsp;Ian Eardley,&nbsp;Ludwik K Trejdosiewicz,&nbsp;Jennifer Southgate","doi":"10.14440/bladder.2015.33","DOIUrl":"https://doi.org/10.14440/bladder.2015.33","url":null,"abstract":"<p><strong>Objective: </strong>Tight junctions are multicomponent structures, with claudin proteins defining paracellular permeability. Claudin 3 is a candidate for the exceptional \"tightness\" of human urothelium, being localised to the terminal tight junction (TJ) of superficial cells. Our aim was to determine whether claudin 3 plays an instigating and/or a functional role in the urothelial TJ.</p><p><strong>Materials and methods: </strong>Normal human urothelial (NHU) cells maintained as non-immortalised cell lines were retrovirally-transduced to over-express or silence claudin 3 expression. Stable sublines induced to stratify or differentiate were assessed for TJ formation by immunocytochemistry and transepithelial electrical resistance (TER). Expression of claudin 3, ZO-1 and ZO-1α<sup>+</sup> was examined in native urothelium by immunohistochemistry.</p><p><strong>Results: </strong>Claudin 3 expression was associated with differentiation and development of a tight barrier and along with ZO-1 and ZO-1α<sup>+</sup> was localised to the apical tight junction in native urothelium. Knockdown of claudin 3 inhibited formation of a tight barrier in three independent cell lines, however, overexpression of claudin 3 was not sufficient to induce tight barrier development in the absence of differentiation. A differentiation-dependent induction of the ZO-1α<sup>+</sup> isoform was found to coincide with barrier formation. Whereas claudin 3 overexpression did not induce the switch to co-expression of ZO-1α<sup>-</sup>/ZO-1α<sup>+</sup>, claudin 3 knockdown decreased localisation of ZO-1 to the TJ and resulted in compromised barrier function.</p><p><strong>Conclusions: </strong>Urothelial cytodifferentiation is accompanied by induction of claudin 3 which is essential for the development of a terminal TJ. A coordinated switch to the ZO-1α<sup>+</sup> isotype was also observed and for the first time may indicate that ZO-1α<sup>+</sup> is involved in the structural assembly and function of the urothelial terminal TJ.</p>","PeriodicalId":72421,"journal":{"name":"Bladder (San Francisco, Calif.)","volume":"2 1","pages":"e9"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c0/3e/nihms667737.PMC4530542.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33917105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 26
期刊
Bladder (San Francisco, Calif.)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1